This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Martin Tremblay: Innovator in Pharmaceutical Compounds
Introduction
Martin Tremblay is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase. His work is essential in advancing therapeutic options for various medical conditions.
Latest Patents
Martin Tremblay holds a patent for "Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase." This patent includes compounds of formula (VII), which are recognized for their utility in inhibiting the aforementioned enzymes. Additionally, the patent encompasses pharmaceutical compositions, kits that include these compounds, and methods and uses related to them.
Career Highlights
Martin Tremblay is affiliated with the University of Texas System, where he continues to engage in innovative research. His work has led to advancements in understanding and utilizing specific compounds for therapeutic purposes.
Collaborations
He has collaborated with notable colleagues, including Richard T. Lewis and Matthew Michael Hamilton, contributing to a dynamic research environment that fosters innovation.
Conclusion
Martin Tremblay's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile